- Home
- ALVR vs KLXE Comparison
ALVR vs KLXE Comparison
Compare ALVR & KLXE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALVR
- KLXE
- Stock Information
- Founded
- ALVR 2013
- KLXE 2018
- Country
- ALVR United States
- KLXE United States
- Employees
- ALVR N/A
- KLXE N/A
- Industry
- ALVR Biotechnology: Biological Products (No Diagnostic Substances)
- KLXE Oilfield Services/Equipment
- Sector
- ALVR Health Care
- KLXE Energy
- Exchange
- ALVR Nasdaq
- KLXE Nasdaq
- Market Cap
- ALVR 87.7M
- KLXE 90.4M
- IPO Year
- ALVR 2020
- KLXE N/A
- Fundamental
- Price
- ALVR $0.94
- KLXE $4.49
- Analyst Decision
- ALVR Sell
- KLXE Hold
- Analyst Count
- ALVR 5
- KLXE 1
- Target Price
- ALVR $1.00
- KLXE $4.50
- AVG Volume (30 Days)
- ALVR 155.6K
- KLXE 92.5K
- Earning Date
- ALVR 11-04-2024
- KLXE 11-04-2024
- Dividend Yield
- ALVR N/A
- KLXE N/A
- EPS Growth
- ALVR N/A
- KLXE N/A
- EPS
- ALVR N/A
- KLXE N/A
- Revenue
- ALVR N/A
- KLXE $769,700,000.00
- Revenue This Year
- ALVR N/A
- KLXE N/A
- Revenue Next Year
- ALVR N/A
- KLXE $3.17
- P/E Ratio
- ALVR N/A
- KLXE N/A
- Revenue Growth
- ALVR N/A
- KLXE N/A
- 52 Week Low
- ALVR $0.58
- KLXE $4.18
- 52 Week High
- ALVR $2.49
- KLXE $12.13
- Technical
- Relative Strength Index (RSI)
- ALVR 69.10
- KLXE 33.44
- Support Level
- ALVR $0.74
- KLXE $4.31
- Resistance Level
- ALVR $0.91
- KLXE $4.59
- Average True Range (ATR)
- ALVR 0.06
- KLXE 0.31
- MACD
- ALVR 0.01
- KLXE -0.05
- Stochastic Oscillator
- ALVR 94.50
- KLXE 8.92
About ALVR AlloVir Inc.
AlloVir Inc is a late clinical-stage cell therapy company. The company focuses on developing innovative allogeneic T-cell therapies to combat viral diseases. Their proprietary VST therapy platform enables the creation of off-the-shelf VSTs, addressing the urgent medical need for treating patients with limited viral disease treatment options. With a singular focus on research, development, and commercialization, the company's platform targets 11 devastating viruses, with posoleucel being the lead candidate addressing six viruses. Operating within one segment, the company is dedicated to preventing and treating severe viral-associated diseases through off-the-shelf VST therapies.
About KLXE KLX Energy Services Holdings Inc.
KLX Energy Services Holdings Inc is a provider of completion, intervention and production services and products to the onshore oil and gas producing regions of the United States. It serves the companies engaged in the exploration and development of onshore conventional and unconventional oil and natural gas reserves. Its products and services offerings include surface facilities and equipment, pressure control services, wireline services, fishing services, and engineered products. The company's segments include Southwest; Rocky Mountains and Northeast/Mid-Con region. It derives maximum revenue from Northeast/Mid-Con region.